These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32635265)

  • 1. Sodium Intake and Chronic Kidney Disease.
    Borrelli S; Provenzano M; Gagliardi I; Michael A; Liberti ME; De Nicola L; Conte G; Garofalo C; Andreucci M
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt and hypertension in end-stage renal disease.
    Kooman JP; Leunissen KM; Luik AJ
    Blood Purif; 1998; 16(6):301-11. PubMed ID: 10343076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered dietary salt intake for people with chronic kidney disease.
    McMahon EJ; Campbell KL; Bauer JD; Mudge DW
    Cochrane Database Syst Rev; 2015 Feb; (2):CD010070. PubMed ID: 25691262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease.
    Taylor AHM; Rankin AJ; McQuarrie EP; Freel EM; Homer NZM; Andrew R; Jardine AG; Mark PB
    Clin Sci (Lond); 2018 Jan; 132(2):285-294. PubMed ID: 29321218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered dietary salt intake for people with chronic kidney disease.
    McMahon EJ; Campbell KL; Bauer JD; Mudge DW; Kelly JT
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD010070. PubMed ID: 34164803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium and water dynamics in the progression of chronic kidney disease: mechanisms and clinical significance.
    Spahia N; Rroji M; Idrizi A; Spasovski G; Barbullushi M
    Int Urol Nephrol; 2024 Jun; 56(6):1953-1963. PubMed ID: 38200365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt intake, blood pressure, and cardiovascular structure.
    Beil AH; Schmieder RE; Messerli FH
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):425-32. PubMed ID: 7947357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in CKD: Core Curriculum 2019.
    Ku E; Lee BJ; Wei J; Weir MR
    Am J Kidney Dis; 2019 Jul; 74(1):120-131. PubMed ID: 30898362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial.
    McMahon EJ; Bauer JD; Hawley CM; Isbel NM; Stowasser M; Johnson DW; Hale RE; Campbell KL
    BMC Nephrol; 2012 Oct; 13():137. PubMed ID: 23082956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease.
    Humalda JK; Navis G
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):533-40. PubMed ID: 25222815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
    Faucon AL; Flamant M; Metzger M; Boffa JJ; Haymann JP; Houillier P; Thervet E; Vrtovsnik F; Stengel B; Geri G; Vidal-Petiot E;
    Kidney Int; 2019 Oct; 96(4):1020-1029. PubMed ID: 31477263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
    Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
    Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spot Urine-guided Salt Reduction in Chronic Kidney Disease Patients.
    Uchiyama K; Yanai A; Ishibashi Y
    J Ren Nutr; 2017 Sep; 27(5):311-316. PubMed ID: 28579314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload.
    Zoccali C; Mallamaci F
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1432-1434. PubMed ID: 30111588
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium intake, RAAS-blockade and progressive renal disease.
    de Borst MH; Navis G
    Pharmacol Res; 2016 May; 107():344-351. PubMed ID: 27041482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.
    Hung SC; Lai YS; Kuo KL; Tarng DC
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.